Scientific Opinion on the substantiation of health claims related to glucosamine alone or in combination with chondroitin sulphate and maintenance of joints (ID 1561, 1562, 1563, 1564, 1565) and reduction of inflammation (ID 1869) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Tabs

Article
Panel on Dietetic Products, Nutrition and Allergies
EFSA Journal
EFSA Journal 2009; 7(9):1264 [17 pp.].
doi
10.2903/j.efsa.2009.1264
Panel members at the time of adoption
Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen
Contact
Type
Opinion of the Scientific Committee/Scientific Panel
On request from
European Commission
Question Number
EFSA-Q-2008-2298
EFSA-Q-2008-2299
EFSA-Q-2008-2300
EFSA-Q-2008-2301
EFSA-Q-2008-2302
EFSA-Q-2008-2602
Adopted
2. Juli 2009
Published in the EFSA Journal
1. Oktober 2009
Last Updated
24. November 2009. This version replaces the previous one/s.
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Abstract

No abstract available

Keywords
Glucosamine, chondroitin sulphate, joints, inflammation, health claims.
Print on demand
Number of Pages
17